CurifyLabs - About the company
CurifyLabs is a series A company based in Helsinki (Finland), founded in 2021 by Niklas Sandler Topelius. It operates as a Provider of digital 3D printing solutions for personalized medicine. CurifyLabs has raised $33.8M in funding from investors like Healthcap, Sandwater and Springvest. The company has 82 active competitors, including 14 funded and 11 that have exited. Its top competitors include companies like Aprecia Pharmaceuticals, Xlife sciences and ROKIT Healthcare.
Company Details
Provider of digital 3D printing solutions for personalized medicine. The company has developed a platform that enables sustainable, quality-controlled production of personalized medicine through its pharmaceutical printing technology. It is a smart drug formulation platform that incorporates cutting-edge technology to redefine the drug compounding process.
- Website
- curifylabs.com
- Social
- Phone Number
- +358 **********
- Registered Address
- ANTENNA CREATIVE BUSINESS CENTRE,15 BECK STREET,NOTTINGHAM,ENGLAND,NG1 1EQ
Key Metrics
Founded Year
2021
Location
Helsinki, Finland
Stage
Series A
Total Funding
$33.8M in 5 rounds
Latest Funding Round
Ranked
3rd among 82 active competitors
Employee Count
49 as on Sep 30, 2026
Similar Companies
Legal entities associated with CurifyLabs
CurifyLabs is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
CURIFY LIMITED CIN: 13571661 , United Kingdom, Active | Aug 16, 2021 | - | 1 (As on Aug 31, 2022) |
Sign up to download CurifyLabs' company profile
CurifyLabs's funding and investors
CurifyLabs has raised a total funding of $33.8M over 5 rounds. Its first funding round was on Jan 11, 2023. Its latest funding round was a Series A round on Jul 06, 2026 for $*****. 4 investors participated in its latest round. CurifyLabs has 10 institutional investors.
Here is the list of recent funding rounds of CurifyLabs:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 06, 2026 | 7480187 | Series A | 7876611 | 5830802 | 4022556 | 5035824 |
May 27, 2025 | 2579489 | Series A | 9406054 | 7131842 | 7353607 | 1385743 |
May 27, 2025 | 8806178 | Conventional Debt | 7609867 | 8880755 | 2144092 |
Access funding benchmarks and valuations. Sign up today!View details of CurifyLabs's funding rounds and investors
CurifyLabs' founders and board of directors
Founder? Claim ProfileThe founders of CurifyLabs is Niklas Sandler Topelius.
Here are the details of CurifyLabs' key team members:
- Niklas Sandler Topelius: Co-Founder of CurifyLabs. Contact Info: 1 email address
View details of CurifyLabs's Founder profiles and Board Members
CurifyLabs' employee count trend
CurifyLabs has 49 employees as of Sep 26. Here is CurifyLabs's employee count trend over the years:
Uncover CurifyLabs' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
CurifyLabs's Competitors and alternates
Top competitors of CurifyLabs include Aprecia Pharmaceuticals, Xlife sciences and ROKIT Healthcare. Here is the list of Top 10 competitors of CurifyLabs, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Aprecia Pharmaceuticals 2003, Langhorne (United States), Acquired | Develops & manufactures orodispersible formulations of highly prescribed high-dose medications using proprietary drug delivery systems. | $176M | 60/100 | |
2nd |  Xlife sciences 2013, Zurich (Switzerland), Public | Developer of drugs for multiple diseases | $62.8M | - | 58/100 |
3rd |  CurifyLabs 2021, Helsinki (Finland), Series A | Provider of digital 3D printing solutions for personalized medicine | $33.8M | 60/100 | |
4th | ROKIT Healthcare 2012, Seoul (South Korea), Public | Provider of 4D bio-printer solutions for tissue regenerative | $30M | 54/100 | |
5th | Allevi 2014, Philadelphia (United States), Acquired | 3D bioprinting solutions: bioprinters, bioinks, and software for tissue engineering | $2.33M | 47/100 | |
6th | FabRx 2014, London (United Kingdom), Unfunded | 3D printed drugs | - | - | 47/100 |
7th | _1568284234590.png?devicePixelRatio=2&height=30&width=30){kind=logo} CTIBiotech 2009, Lyon (France), Funding Raised | Develops 3D human tissue models | - | 46/100 | |
8th | Developer of 3D tissue engineering technology | $16.6M | 45/100 | ||
9th |  BICO 2016, Boston (United States), Public | Provider of technologies, products, and services for life sciences research purposes | - | 45/100 | |
10th | CELLINK 2016, Boston (United States), Public | Developer of 3D bioprinters and bioinks for research purposes | - | 43/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on CurifyLabs's competitors? Click here to see the top ones
CurifyLabs's Investments and acquisitions
CurifyLabs has made no investments or acquisitions yet.
Reports related to CurifyLabs
Here is the latest report on CurifyLabs's sector:
News related to CurifyLabs
Filter this listMedia has covered CurifyLabs for a total of 5 events in the last 1 year, 2 of them have been about company updates.
•
Finnish 3D Printed Pharma OEM CurifyLabs Lands $14M Series A3DPrint.com•Aug 01, 2026•HealthCap, CurifyLabs, Sandwater
•
Finnish Healthtech Startup CurifyLabs Raises €12 Million in Series A RoundStartup Rise EU•Jul 06, 2026•Healthcap, CurifyLabs, Sandwater, HealthCap and 1 other
•
CurifyLabs raises $14 million to scale personalized medicine productionTesi•Jun 07, 2026•Tesi, CurifyLabs, Sandwater, Healthcap and 1 other
•
CurifyLabs unveils Curablend Vet, a 3D-printed medicine system for pets.TCT Magazine•Dec 10, 2025•CurifyLabs
•
CurifyLabs launches next-gen software platform for 3D printed compounded medication, boosting pharmacist design flexibilityTCT Magazine•Oct 28, 2025•CurifyLabs
•
CurifyLabs Secures €6.7M Funding for Personalized Medicine AutomationStartup Rise EU•May 28, 2025•CurifyLabs
•
APL and CurifyLabs Partner for 3D-Printed MedicinesContract Pharma•Sep 05, 2024•Apotek Produktion & Laboratorier, CurifyLabs
•
CurifyLabs acquires IP from Mehta Heino, boosting 3D printed personalised medicine production.Tech.eu•Jan 17, 2024•CurifyLabs, Mehta Heino Industries
•
CurifyLabs launches 3D printing solution for personalised medicineTCT Magazine•Oct 17, 2023•CurifyLabs
•
Finland’s CurifyLabs awarded €2.5 million from European Innovation CouncilTech.eu•Apr 03, 2023•CurifyLabs, Europa, European Innovation Council
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about CurifyLabs
Explore our recently published companies
- Sraml - Slovenia based, 1993 founded, Unfunded company
- Endless - Sabadell based, 2015 founded, Unfunded company
- LiveMax - Minato based, 1998 founded, Unfunded company
- Vincent Minichiello - United States based, 2023 founded, Unfunded company
- NeuroSport Physical Therapy - South Pasadena based, 2017 founded, Unfunded company
- Kiscol Grands - Coimbatore based, Unfunded company
